Prospective phase II trial of alternating intravesical Bacillus Calmette-Gu�rin (BCG) and Interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: Preliminary results - Concepedia

Concepedia

Publication | Closed Access

Prospective phase II trial of alternating intravesical Bacillus Calmette-Gu�rin (BCG) and Interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: Preliminary results

12

Citations

17

References

2000

Year

Shouki Bazarbashi, M.A. Raja, Amer Sayed, Adnan Ezzat, Ezzeldin M. Ibrahim, Said Kattan, Abdul Hafeez Kardar, Amjad Peracha, E Lindstedt, Kamal A. Hanash

Journal of Surgical Oncology

Abstract

Alternating intravesical BCG and IFN is effective and well tolerated therapy for superficial TCC of urinary bladder.

References

	Year	Citations

Page 1